Luteinising Hormone
Note: In some countries, this medicine may only be approved for veterinary use.
CAS registry number (Chemical Abstracts Service)
0009002-67-9
Therapeutic Category
Pituitary gonadotropin: Luteinizing hormone (LH)
Chemical Name
Glycoprotein.Heterodimer of non-covalently linked unspecific α- and specific β-glycopeptidic subunits, isolated from anterior pituitary.
Foreign Names
- Lutropinum (Latin)
- Luteinisierendes Hormon (German)
- Hormone lutéinisante (French)
- Lutropina (Spanish)
Generic Names
- Gonadotropin B (IS)
- ICSH (IS)
- Interstitial cell stimulating hormone (IS)
- LH (IS)
- Luteotropic Hormone (IS)
- Pituitary Luteinizing Hormone (IS)
- PLH (IS)
- Prolan B (IS)
Brand Names
- Grafova [+ Follicle Stimulating Hormone]
Glenmark, India - HMG Ferring [+ Follicle Stimulating Hormone]
Ferring, Argentina - Lifecell [+ Follicle Stimulating Hormone]
Buxton, Argentina - Lutein
Arion Mason, Peru - Menofactor
Biofactor, Egypt - Menogon [+ Follicle Stimulating Hormone]
Ferring, Israel - Pergonal
Serono, Egypt - Pergoveris [+ Follicle Stimulating Hormone]
Merck, Indonesia; Merck Serono, Poland; Serono, Tunisia - Pluset [+ Follicle Stimulating Hormone] [veterinary use]
Vetcare, Finland; Laboratorios Calier, Belgium; Laboratorios Calier, Ireland; Laboratorios Calier, Netherlands; Laboratorios Calier, SA, United Kingdom; Qalian, France
Glossary
| Term | Definition |
|---|---|
| IS | Inofficial Synonym |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
